s6y
Company name or ticker
Search
Telomir Pharmaceuticals, Inc.
4
Del Giudice Matthew Paul: Statement of changes in beneficial ownership of securities
Filed
Friday, May 22, 2026
Period
May 21, 2026
Accession number
0001493152-26-025113
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header